BIOMAT Database Logo BIOMAT Database Logo

Metastatic Crohn Disease Treated With Ustekinumab. 2021

Rosa Ballester Sánchez, and Celia Sanchís Sánchez, and Beatriz Rodrigo Nicolás, and Francisca Valcuende Cavero
Servicio de Dermatología. Hospital Universitari de La Plana, Villarreal, Castellón, España. Electronic address: roseta999@hotmail.com.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D003424 Crohn Disease A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. Colitis, Granulomatous,Enteritis, Granulomatous,Enteritis, Regional,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,Crohn's Disease,Crohn's Enteritis,Inflammatory Bowel Disease 1,Regional Enteritis,Crohns Disease,Granulomatous Colitis,Granulomatous Enteritis,Regional Ileitides,Regional Ileitis,Terminal Ileitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069549 Ustekinumab A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies. CNTO 1275,CNTO-1275,Stelara
D016609 Neoplasms, Second Primary Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause. Neoplasms, Metachronous,Neoplasms, Metachronous Second Primary,Neoplasms, Therapy-Related,Neoplasms, Treatment-Related,Second Malignancy,Second Neoplasm,Second Primary Neoplasms,Therapy-Associated Neoplasms,Therapy-Related Cancer,Treatment-Associated Neoplasms,Treatment-Related Cancer,Cancer, Second Primary,Metachronous Neoplasms,Metachronous Second Primary Neoplasms,Neoplasms, Therapy-Associated,Neoplasms, Treatment-Associated,Second Cancer,Second Primary Neoplasms, Metachronous,Therapy-Associated Cancer,Therapy-Related Neoplasms,Treatment-Associated Cancer,Treatment-Related Neoplasms,Cancer, Second,Cancer, Therapy-Associated,Cancer, Therapy-Related,Cancer, Treatment-Associated,Cancer, Treatment-Related,Cancers, Second,Cancers, Second Primary,Cancers, Therapy-Associated,Cancers, Therapy-Related,Cancers, Treatment-Associated,Cancers, Treatment-Related,Malignancies, Second,Malignancy, Second,Metachronous Neoplasm,Neoplasm, Metachronous,Neoplasm, Second,Neoplasm, Second Primary,Neoplasm, Therapy-Associated,Neoplasm, Therapy-Related,Neoplasm, Treatment-Associated,Neoplasm, Treatment-Related,Neoplasms, Second,Neoplasms, Therapy Associated,Neoplasms, Therapy Related,Neoplasms, Treatment Associated,Neoplasms, Treatment Related,Second Cancers,Second Malignancies,Second Neoplasms,Second Primary Cancer,Second Primary Cancers,Second Primary Neoplasm,Therapy Associated Cancer,Therapy Associated Neoplasms,Therapy Related Cancer,Therapy Related Neoplasms,Therapy-Associated Cancers,Therapy-Associated Neoplasm,Therapy-Related Cancers,Therapy-Related Neoplasm,Treatment Associated Cancer,Treatment Associated Neoplasms,Treatment Related Cancer,Treatment Related Neoplasms,Treatment-Associated Cancers,Treatment-Associated Neoplasm,Treatment-Related Cancers,Treatment-Related Neoplasm

Related Publications

Rosa Ballester Sánchez, and Celia Sanchís Sánchez, and Beatriz Rodrigo Nicolás, and Francisca Valcuende Cavero
Amoebic Liver Abscess in Crohn Disease Treated With Ustekinumab.
June 2020, Inflammatory bowel diseases,
Rosa Ballester Sánchez, and Celia Sanchís Sánchez, and Beatriz Rodrigo Nicolás, and Francisca Valcuende Cavero
Ustekinumab for Crohn Disease With Severe Gastroduodenal Involvement.
October 2021, Inflammatory bowel diseases,
Rosa Ballester Sánchez, and Celia Sanchís Sánchez, and Beatriz Rodrigo Nicolás, and Francisca Valcuende Cavero
Ustekinumab in Pediatric Crohn Disease Patients.
September 2016, Journal of pediatric gastroenterology and nutrition,
Rosa Ballester Sánchez, and Celia Sanchís Sánchez, and Beatriz Rodrigo Nicolás, and Francisca Valcuende Cavero
Ustekinumab for Resistant Pediatric Crohn Disease.
April 2016, Journal of pediatric gastroenterology and nutrition,
Rosa Ballester Sánchez, and Celia Sanchís Sánchez, and Beatriz Rodrigo Nicolás, and Francisca Valcuende Cavero
Ustekinumab in Treatment of Refractory Paediatric Crohn Disease.
March 2016, Journal of pediatric gastroenterology and nutrition,
Rosa Ballester Sánchez, and Celia Sanchís Sánchez, and Beatriz Rodrigo Nicolás, and Francisca Valcuende Cavero
Metastatic Crohn disease improving with vedolizumab.
July 2023, The British journal of dermatology,
Rosa Ballester Sánchez, and Celia Sanchís Sánchez, and Beatriz Rodrigo Nicolás, and Francisca Valcuende Cavero
Metastatic Crohn disease: clearance with metronidazole.
February 2011, Journal of the American Academy of Dermatology,
Rosa Ballester Sánchez, and Celia Sanchís Sánchez, and Beatriz Rodrigo Nicolás, and Francisca Valcuende Cavero
Metastatic Cutaneous Crohn's Disease of the Face-A Case Successfully Treated With Ustekinumab.
July 2020, Journal of Crohn's & colitis,
Rosa Ballester Sánchez, and Celia Sanchís Sánchez, and Beatriz Rodrigo Nicolás, and Francisca Valcuende Cavero
Experience Using Ustekinumab in Pediatric Patients With Medically Refractory Crohn Disease.
November 2021, Journal of pediatric gastroenterology and nutrition,
Rosa Ballester Sánchez, and Celia Sanchís Sánchez, and Beatriz Rodrigo Nicolás, and Francisca Valcuende Cavero
[Cutaneous metastatic Crohn disease].
December 1989, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
Copied contents to your clipboard!